Experience the GR01 HbA1c analyzer
17 Dec 2025
In this video, Tosoh Bioscience - Diagnostics EMEA introduces the HLC-723® GR01 analyzer, setting a new benchmark in lab efficiency. The analyzer combines intuitive operation and robust reliability to deliver one of the fastest hemoglobin separation methods available, ensuring consistent and accurate HbA1c results.
About the company
Tosoh Bioscience - Diagnostics EMEA
Tosoh Bioscience - Diagnostics EMEA focuses on diagnostic domains such as immunochemistry, HPLC based diabetes, thalassemia screening and molecular biology. We assist our customers in their efforts to respond to the ever-growing clinical demand for faster and more precise diagnosis, by providing solutions that reconcile quality of results and workflow optimization. Therefore, we also offer open laboratory automation hardware and middleware.
Tosoh Bioscience - Diagnostics EMEA is part of the Bioscience Division of Tosoh Corporation, headquartered in Tokyo, Japan.
Related products
Request Quote for All Products
HLC-723® GR01
Tosoh Bioscience - Diagnostics EMEASet a new benchmark in lab efficiency with the HLC-723 GR01 analyzer, which combines intuitive operation and robust reliability. It delivers one of the fastest hemoglobin separation methods available, ensuring consistent and accurate HbA1c results. Beyond diabetes care, GR01 adds clinical value through precise detection of hemoglobin variants, maximizing performance and ROI.
